0

Venous Stents Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21269

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

June 2021

Total pages

112

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

VENOUS STENTS ARE MESH TUBES MADE FROM ALLOY WHICH ARE DEPLOYED IN THE VEINS TO PROVIDE THEM WITH STRUCTURAL SUPPORT. THEY CAN BE OF A VARIETY OF DESIGN AND SIZES. STENTS ARE DELIVERED TO THEIR TARGET AREA USING A VASCULAR CATHETER IN A COMPRESSED STATE. STENTS ARE USUALLY SELF-EXPANDING, BUT SOME REQUIRE ASSISTANCE OF AN INFLATED BALLOON.

MOST STENTS ONCE PLACED DO NOT MOVE EASILY AND CAN BE VERY DIFFICULT TO REMOVE WHEN NEEDED. FURTHERMORE, STENTS CAN BE DESIGNED TO DELIVER MEDICATIONS AS WELL SLOWLY OVER TIME. AS COMPARED TO ARTERIAL STENTS, VENOUS STENTS ARE DESIGNED WITH MORE RADIAL STRENGTH AS THERE IS LESS BLOOD PRESSURE ALONG THE VENOUS SYSTEM. ADDITIONALLY, VENOUS STENTS ARE MORE ELASTIC AS VEINS CONTRACT AND DILATE MORE THAN ARTERIES.

STENTS ARE USED TO TREAT DISEASES WHERE THERE IS A PARTIAL OR COMPLETE REDUCTION IN THE BLOOD FLOW AREA. SOME COMMON DISEASES THAT CAN NEED VENOUS STENTS INCLUDE, POST-THROMBOTIC SYNDROME (PTS), PELVIC CONGESTION SYNDROME (PCS), MAY-THURNER'S SYNDROME (MTS) AND PERIPHERAL ARTERY DISEASE (PAD).

STENTING IS PROVEN TO BE SAFE AND SUCCESSFUL, THEREFORE IT HAS BECOME MORE PREVALENT IN THE PAST DECADES. ONE KEY BENEFIT OF STENTING IS THAT IT CAN BE INSERTED USING A CATHETER WITHOUT ANY NEED FOR AN INVASIVE SURGERY. ADDITIONAL BENEFITS OF VENOUS STENTS INCLUDE: LESS RECOVERY TIME; SHORTER PROCEDURE DURATIONS AND MINIMAL RISK OF COMPLICATION.

BASED ON TECHNOLOGY, THE VENOUS STENTS MARKET IS BIFURCATED INTO ILLIAC VEIN STENT TECHNOLOGY AND WALLSTENT TECHNOLOGY. THE WALLSTENT SEGMENT OF THE MARKET WAS VALUED AT USD XX MILLION IN 2020 AND IS LIKELY TO REACH USD XX MILLION BY 2027 GROWING AT A CAGR OF XX% FROM 2021-2027. WALLSTENTS HAVE BEEN THE MOST COMMON STENT TYPE AVAILABLE SINCE A VERY LONG TIME. MORE THAN 50% OF THE PATIENTS GET WALLSTENTS IN THE UNITED STATES.

BASED ON APPLICATION, THE VENOUS STENTS MARKET IS FRAGMENTED INTO LEGS, CHEST, ABDOMEN, AND OTHERS. THE LEGS SEGMENT OF THE MARKET WAS VALUED AT USD XX MILLION IN 2020 AND IS LIKELY TO REACH USD XX MILLION BY 2027 GROWING AT A CAGR OF XX% FROM 2021-2027. KEY FACTORS THAT MADE LEG SEGMENT THE FRONTRUNNER IS THE INCREASING PREVALENCE OF DEEP VEIN THROMBOSIS.

BASED ON DISEASE, THE VENOUS STENTS MARKET IS FRAGMENTED INTO CHRONIC DEEP VEIN THROMBOSIS, POST THROMBOTIC SYNDROME, AND OTHERS. THE CHRONIC DEEP VEIN SEGMENT OF THE MARKET WAS VALUED AT USD XX MILLION IN 2020 AND IS LIKELY TO REACH USD XX MILLION BY 2027 GROWING AT A CAGR OF XX% FROM 2021-2027. KEY FACTOR INCREASING THE OCCURRENCE OF CHRONIC DEEP VEIN THROMBOSIS IS THE INCREASING GERIATRIC POPULATION.

FOR A BETTER UNDERSTANDING OF THE MARKET ADOPTION OF THE VENOUS STENTS MARKET, THE MARKET IS ANALYSED BASED ON ITS WORLDWIDE PENETRATION IN THE COUNTRIES SUCH AS NORTH AMERICA (UNITED STATES, CANADA, AND REST OF NORTH AMERICA), EUROPE (GERMANY, FRANCE, ITALY, SPAIN, UNITED KINGDOM AND REST OF EUROPE), ASIA-PACIFIC (CHINA, JAPAN, INDIA, AUSTRALIA, AND REST OF APAC), AND REST OF WORLD. NORTH AMERICA CONSTITUTES A MAJOR MARKET FOR THE VENOUS STENTS INDUSTRY AND GENERATED REVENUE OF USD XX MILLION IN 2020 OWING TO THE PRESENCE OF WELL-ESTABLISHED PLAYERS IN THE REGION, RISING HEALTHCARE INVESTMENT BY THE COMPANIES, ETC.

SOME OF THE MAJOR PLAYERS OPERATING IN THE MARKET INCLUDE BOSTON SCIENTIFIC CORPORATION, MEDTRONIC PLC, BECTON, DICKINSON AND COMPANY, MEDICA GERMANY GMBH & CO. KG, COOK MEDICAL, W. L. GORE & ASSOCIATES, INC., CORDIS, JOTEC GMBH, ABBOTT LABORATORIES, OPTIMED MEDIZINISCHE INSTRUMENTE GMBH. SEVERAL M&A'S ALONG WITH PARTNERSHIPS HAVE BEEN UNDERTAKEN BY THESE PLAYERS TO BOOST THEIR PRESENCE IN DIFFERENT REGIONS.

Products


Companies

BOSTON SCIENTIFIC CORPORATION

MEDTRONIC PLC

BECTON

DICKINSON AND COMPANY

MEDICA GERMANY GMBH & CO. KG

COOK MEDICAL

W. L. GORE & ASSOCIATES

INC.

CORDIS

JOTEC GMBH

ABBOTT LABORATORIES

AND OPTIMED MEDIZINISCHE INSTRUMENTE GMBH

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. MARKET DEFINITIONS

1.2. OBJECTIVE OF THE STUDY

1.3. LIMITATION

1.4. STAKE HOLDERS

1.5. CURRENCY USED IN REPORT

1.6. SCOPE OF THE VENOUS STENTS MARKET STUDY

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. RESEARCH METHODOLOGY FOR THE VENOUS STENTS MARKET

2.1.1. MAIN OBJECTIVE OF THE VENOUS STENTS MARKET

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY TECHNOLOGY

6.1. ILIAC VEIN STENT TECHNOLOGY

6.2. WALLSTENT TECHNOLOGY

7 MARKET INSIGHTS BY APPLICATION

7.1. LEG

7.2. CHEST

7.3. ABDOMEN

7.4. OTHERS

8 MARKET INSIGHTS BY DISEASE

8.1. CHRONIC DEEP VEIN THROMBOSIS

8.2. POST THROMBOTIC SYNDROME

8.3. OTHERS

9 MARKET INSIGHTS BY REGION

9.1. NORTH AMERICA VENOUS STENTS MARKET

9.1.1. UNITED STATES OF AMERICA

9.1.2. CANADA

9.1.3. REST OF NORTH AMERICA

9.2 EUROPE VENOUS STENTS MARKET

9.2.1. UNITED KINGDOM

9.2.2. GERMANY

9.2.3. FRANCE

9.2.4. SPAIN

9.2.5. ITALY

9.2.6. REST OF EUROPE

9.3. ASIA-PACIFIC VENOUS STENTS MARKET

9.3.1. CHINA

9.3.2. JAPAN

9.3.3. INDIA

9.3.4. AUSTRALIA

9.3.5. REST OF ASIA-PACIFIC

9.4. REST OF THE WORLD VENOUS STENTS MARKET

10 LEGAL AND REGULATORY FRAMEWORK

11 DEMAND AND SUPPLY SIDE ANALYSIS

11.1. DEMAND SIDE ANALYSIS

11.2. SUPPLY SIDE ANALYSIS

11.2.1. TOP PRODUCT LAUNCHES

11.2.2. TOP BUSINESS PARTNERSHIPS

11.2.3. TOP BUSINESS EXPANSIONS, INVESTMENTS AND DIVESTITURES

11.2.4. TOP MERGER AND ACQUISITIONS

12 VALUE CHAIN ANALYSIS

13 VENOUS STENTS MARKET TRENDS & INSIGHTS

14 VENOUS STENTS MARKET DYNAMICS

14.1. DRIVERS

14.2. CHALLENGES

14.3. IMPACT ANALYSIS

14.4. OPPORTUNITY

15 COMPETITIVE SCENARIO

15.1. VENOUS STENTS MARKET SHARE, BY COMPANY 2020

16 COMPANY PROFILED

16.1. BOSTON SCIENTIFIC CORPORATION

16.2. MEDTRONIC PLC

16.3. BECTON, DICKINSON AND COMPANY

16.4. MEDICA GERMANY GMBH & CO. KG

16.5. COOK MEDICAL

16.6. W. L. GORE & ASSOCIATES, INC.

16.7. CORDIS

16.8. JOTEC GMBH

16.9. ABBOTT LABORATORIES

16.10. OPTIMED MEDIZINISCHE INSTRUMENTE GMBH

17 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022